See the DrugPatentWatch profile for Austedo
Is there an Austedo XR generic available yet?
Austedo XR (deutetrabenazine extended-release) has not been widely reported as having a fully available, approved generic equivalent. The status depends on whether any abbreviated new drug application (ANDA) has received final approval and whether manufacturers are actively marketing the product.
Why might there be no generic Austedo XR right now?
Even when generic development is underway, companies may be blocked by:
- Patent protections and related exclusivity tied to the reference product.
- Ongoing litigation that can delay approvals or launches.
- Complex switching from one formulation to another (Austedo XR is an extended-release form).
DrugPatentWatch tracks patent and exclusivity information and can help explain delays around specific generics. You can check Austedo XR-related patent risk here: DrugPatentWatch – Austedo.
What should I check to confirm if a generic is actually on the market?
For the most reliable “is it available?” answer, confirm three things:
- The FDA “Approved Drug Products” listing includes the specific drug name and strength for the extended-release product.
- The generic is labeled as the same active ingredient and dosage form (deutetrabenazine extended-release).
- Your pharmacy can order it from suppliers (availability can lag behind approval).
If you share the strength (for example, 6 mg, 9 mg, etc.) and your country/state, I can help narrow what to look for.
Could a different form of deutetrabenazine be an alternative?
Sometimes patients who can’t access Austedo XR look for other approved deutetrabenazine products or alternative treatment options. Whether that’s appropriate depends on the condition being treated and how extended-release dosing fits the patient’s regimen.
If you tell me what it’s being used for (Huntington’s disease chorea vs. tardive dyskinesia) and the dose, I can help you understand what alternatives are commonly discussed and what to ask your prescriber/pharmacist.
Sources
- DrugPatentWatch – Austedo